Sequana Medical - alfapump system

Startpagina
België
Sint-Denijs-Westrem
Sequana Medical - alfapump system

Over 900 alfapump® systems have been implanted.

The alfapump®, is a fully implantable, programmable, wirelessly-charged, battery-powered system that is CE-marked for the treatment of refractory ascites due to liver cirrhosis and malignant ascites. The alfapump® has been endorsed by key independent third parties in Europe and has received Breakthrough Device status from the US FDA. We have leveraged our alfapump® technology experience and are de

veloping alfapump DSR®, a novel and proprietary approach to the treatment of fluid overload in patients suffering from heart failure.

08/06/2026

Did you know Penn Medicine offers the alfapump System at its dedicated Ascites Clinic? Their team of liver specialists, dietitians, and interventional radiologists works together to provide comprehensive care for patients living with recurrent or refractory ascites due to liver cirrhosis.

If you or someone you know has been managing ascites through repeated paracentesis procedures, learn more about whether the alfapump may be an option.

https://www.pennmedicine.org/treatments/alfapump

For important safety information, visit:https://www.sequanamedical.com/wp-content/uploads/ISI.pdf

03/06/2026

For patients living with recurrent or refractory ascites due to liver cirrhosis, the impact on daily life can be devastating. Hear from Berto about his experience with the alfapump System and how it gave his body the chance to recover. Now, 2½ years later, he no longer needs the pump and is looking toward the future.

Patient testimonial represents one individual’s experience. Individual results may vary.

IMPORTANT SAFETY INFORMATION: The alfapump® System is intended for single patient use only in adult patients with refractory or recurrent ascites due to liver cirrhosis. It is indicated for the removal of excess peritoneal fluid from the peritoneal cavity into the bladder, where it can be eliminated through normal urination. Important risks include: peritoneal cavity infections, pump pocket complications, catheter-related issues, and genito-urinary complications. The system is MRI unsafe. For full important safety information, visit:https://www.sequanamedical.com/wp-content/uploads/ISI.pdf

Complete interview on file at Sequana Medical.

29/05/2026

For patients living with recurrent or refractory ascites due to liver cirrhosis, the impact on daily life can be profound. Hear from Lisa about her experience with the alfapump System and how it helped her get back to living, from sleeping comfortably and eating well, to taking walks and driving again.

Patient testimonial represents one individual’s experience. Individual results may vary.

IMPORTANT SAFETY INFORMATION: The alfapump® System is intended for single patient use only in adult patients with refractory or recurrent ascites due to liver cirrhosis. It is indicated for the removal of excess peritoneal fluid from the peritoneal cavity into the bladder, where it can be eliminated through normal urination. Important risks include: peritoneal cavity infections, pump pocket complications, catheter-related issues, and genito-urinary complications. The system is MRI unsafe.

For full important safety information, visit:https://www.sequanamedical.com/wp-content/uploads/ISI.pdf

27/05/2026

Living with the alfapump System is designed to be as simple as possible. Once implanted, the only daily requirement is a 20-minute wireless recharge, using a smart charger held over the abdomen. No external tubes, no repeated hospital visits for drainage. Just like charging a phone.

Learn more at sequanamedical.com

For important safety information, visit:https://www.sequanamedical.com/wp-content/uploads/ISI.pdf

21/05/2026

For patients living with recurrent or refractory ascites due to liver cirrhosis, the impact on daily life can be significant. Hear from Ron about his experience with the alfapump System and how it changed his life, from eating and sleeping well again, to returning to work and getting back to normal physical activity.

Patient testimonial represents one individual’s experience. Individual results may vary.

IMPORTANT SAFETY INFORMATION: The alfapump® System is intended for single patient use only in adult patients with refractory or recurrent ascites due to liver cirrhosis. It is indicated for the removal of excess peritoneal fluid from the peritoneal cavity into the bladder, where it can be eliminated through normal urination. Important risks include: peritoneal cavity infections, pump pocket complications, catheter-related issues, and genito-urinary complications. The system is MRI unsafe.

For full important safety information, visit:https://www.sequanamedical.com/wp-content/uploads/ISI.pdf

19/05/2026

The pivotal POSEIDON study, published in the American Journal of Gastroenterology, assessed the safety and efficacy of the alfapump System in patients with recurrent or refractory ascites due to liver cirrhosis.

The study found that implantation significantly reduced the need for therapeutic paracentesis, with the majority of patients achieving a meaningful reduction in drainage procedures. Patients also reported significant improvements in quality of life, including an average of 10 additional good health days per month.

Read the full publication: https://journals.lww.com/ajg/fulltext/2025/10000/the_effects_of_alfapump_on_ascites_control_and.21.aspx

For important safety information, visit:https://www.sequanamedical.com/wp-content/uploads/ISI.pdf

04/05/2026

May is Hepatitis Awareness Month, a timely reminder that viral hepatitis, if left untreated, can lead to cirrhosis, liver failure, and liver cancer. Millions of people are living with chronic hepatitis B or C without knowing it, and for those who do develop advanced liver disease, the consequences can be life-altering.

At Sequana Medical, we work every day for patients navigating the serious complications of advanced liver disease, including those living with recurrent or refractory ascites due to liver cirrhosis.

This month, we stand with the hepatitis awareness community in encouraging adults to get tested and vaccinated.

https://www.cdc.gov/hepatitis-awareness/about/index.html

24/04/2026

The alfapump System is the first and only FDA-approved active implantable medical device for the treatment of recurrent or refractory ascites due to liver cirrhosis.

Here’s how it works:

The pump is implanted under the skin in an approximately 80-minute procedure performed by an interventional radiologist. Once in place, it automatically and continuously moves fluid from the abdomen to the bladder, where it is naturally eliminated. No needles. No external tubes. No repeated hospital visits for drainage.

The only daily requirement for patients is a simple 20-minute wireless recharge, similar to charging a phone. During that time, pump performance data is collected and this enables the Sequana team to send regular reports to the treating physician, providing important insights on the patient’s progress with the alfapump.

For patients who have lived around the schedule of paracentesis, that is a meaningful shift.

Learn more at https://www.sequanamedical.com/

For important safety information, visit:https://www.sequanamedical.com/wp-content/uploads/ISI.pdf

20/04/2026

The physical demands and frequency of paracentesis procedures can significantly impact patients with ascites due to liver cirrhosis.

David describes his experience with traditional paracentesis treatments, including the physical discomfort and logistical challenges of frequent hospital visits, before receiving the alfapump® System, an FDA-approved treatment for adults with refractory or recurrent ascites due to liver cirrhosis.

Excerpt from full patient story. Full video available at https://www.youtube.com/watch?v=zDkztv5wmpo

Patient testimonial represents one individual’s experience. Individual results may vary.

IMPORTANT SAFETY INFORMATION: The alfapump® System is intended for single patient use only in adult patients with refractory or recurrent ascites due to liver cirrhosis. It is indicated for the removal of excess peritoneal fluid from the peritoneal cavity into the bladder, where it can be eliminated through normal urination.

Important risks include: peritoneal cavity infections, pump pocket complications, catheter-related issues, and genito-urinary complications. The system is MRI unsafe.

For full important safety information, visit:https://www.sequanamedical.com/wp-content/uploads/ISI.pdf

19/04/2026

Today is World Liver Day 🌍

This year’s theme, “Solid Habits, Strong Liver,” is a powerful reminder of how much lifestyle choices impact liver health and why early intervention matters. Metabolic dysfunction-associated steatotic liver disease (MASLD) affects one-third of the global population, but small, steady changes to diet, exercise and drinking habits and regular check-ups can prevent serious complications, like liver scarring, cirrhosis or even liver cancer.

For the 1.5 billion people already living with chronic liver disease worldwide, the stakes are high. At Sequana Medical, we’re focused on those navigating the serious consequences of advanced liver disease, including patients with recurrent or refractory ascites due to liver cirrhosis.

On this World Liver Day, we stand with the global liver disease community in the effort to raise awareness of liver health and improve outcomes and quality of life for patients everywhere.

🔗 worldliverday.org

Adres

Kortrijksesteenweg 1112 Bus 102
Sint-Denijs-Westrem
9051

Website

http://www.alfapump.com/

Meldingen

Wees de eerste die het weet en laat ons u een e-mail sturen wanneer Sequana Medical - alfapump system nieuws en promoties plaatst. Uw e-mailadres wordt niet voor andere doeleinden gebruikt en u kunt zich op elk gewenst moment afmelden.